Swiss National Bank
SUPN icon

Swiss National Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Swiss National Bank’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.87M Buy
113,500
+2,900
+3% +$148K ﹤0.01% 1270
2025
Q4 		$5.5M Buy
110,600
+2,100
+2% +$102K ﹤0.01% 1296
2025
Q3 		$5.19M Buy
108,500
+1,500
+1% +$60.4K ﹤0.01% 1310
2025
Q2 		$3.37M Hold
107,000
– – ﹤0.01% 1497
2025
Q1 		$3.5M Sell
107,000
-1,400
-1% -$49.6K ﹤0.01% 1455
2024
Q4 		$3.92M Buy
108,400
+800
+0.7% +$28.2K ﹤0.01% 1476
2024
Q3 		$3.35M Hold
107,600
– – ﹤0.01% 1562
2024
Q2 		$2.88M Hold
107,600
– – ﹤0.01% 1614
2024
Q1 		$3.67M Hold
107,600
– – ﹤0.01% 1495
2023
Q4 		$3.11M Sell
107,600
-12,100
-10% -$321K ﹤0.01% 1592
2023
Q3 		$3.3M Buy
119,700
+1,300
+1% +$39.6K ﹤0.01% 1528
2023
Q2 		$3.56M Buy
118,400
+1,800
+2% +$63K ﹤0.01% 1516
2023
Q1 		$4.22M Sell
116,600
-12,600
-10% -$484K ﹤0.01% 1382
2022
Q4 		$4.61M Buy
129,200
+2,500
+2% +$86.9K ﹤0.01% 1365
2022
Q3 		$4.29M Buy
126,700
+1,000
+0.8% +$32.5K ﹤0.01% 1372
2022
Q2 		$3.63M Hold
125,700
– – ﹤0.01% 1507
2022
Q1 		$4.06M Buy
125,700
+8,600
+7% +$264K ﹤0.01% 1577
2021
Q4 		$3.42M Hold
117,100
– – ﹤0.01% 1712
2021
Q3 		$3.12M Buy
117,100
+1,000
+0.9% +$26.8K ﹤0.01% 1757
2021
Q2 		$3.58M Sell
116,100
-4,300
-4% -$132K ﹤0.01% 1725
2021
Q1 		$3.15M Buy
120,400
+1,300
+1% +$36.4K ﹤0.01% 1733
2020
Q4 		$3M Hold
119,100
– – ﹤0.01% 1678
2020
Q3 		$2.48M Buy
119,100
+2,000
+2% +$45.4K ﹤0.01% 1613
2020
Q2 		$2.78M Buy
117,100
+15,400
+15% +$340K ﹤0.01% 1522
2020
Q1 		$1.83M Buy
101,700
+1,300
+1% +$27.3K ﹤0.01% 1510
2019
Q4 		$2.38M Buy
100,400
+2,000
+2% +$48.6K ﹤0.01% 1630
2019
Q3 		$2.7M Buy
98,400
+1,100
+1% +$32.6K ﹤0.01% 1484
2019
Q2 		$3.22M Buy
97,300
+2,100
+2% +$72K ﹤0.01% 1395
2019
Q1 		$3.34M Buy
95,200
+2,900
+3% +$108K ﹤0.01% 1342
2018
Q4 		$3.07M Buy
92,300
+2,100
+2% +$90.3K ﹤0.01% 1292
2018
Q3 		$4.54M Hold
90,200
– – 0.01% 1181
2018
Q2 		$5.4M Buy
90,200
+1,800
+2% +$93.2K 0.01% 1039
2018
Q1 		$4.05M Buy
88,400
+2,000
+2% +$83.5K ﹤0.01% 1176
2017
Q4 		$3.44M Buy
86,400
+2,900
+3% +$115K ﹤0.01% 1288
2017
Q3 		$3.34M Hold
83,500
– – ﹤0.01% 1290
2017
Q2 		$3.6M Buy
83,500
+18,200
+28% +$648K ﹤0.01% 1208
2017
Q1 		$2.04M Buy
65,300
+2,100
+3% +$56.3K ﹤0.01% 1545
2016
Q4 		$1.6M Hold
63,200
– – ﹤0.01% 1725
2016
Q3 		$1.56M Sell
63,200
-1,800
-3% -$40.7K ﹤0.01% 1672
2016
Q2 		$1.32M Buy
65,000
+8,700
+15% +$154K ﹤0.01% 1794
2016
Q1 		$830K Buy
56,300
+10,300
+22% +$134K ﹤0.01% 2022
2015
Q4 		$618K Hold
46,000
– – ﹤0.01% 2134
2015
Q3 		$645K Buy
46,000
+6,200
+16% +$115K ﹤0.01% 2041
2015
Q2 		$676K Buy
+39,800
New +$566K ﹤0.01% 2049

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's SUPN Position: Q1 2026 in Review

Swiss National Bank increased its Supernus Pharmaceuticals (SUPN) stake by 2.6% in Q1 2026, buying an estimated $148K and bringing the position to 113,500 shares worth $5.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

Swiss National Bank first reported a position in SUPN in Q2 2015 and has held it in 44 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Swiss National Bank held 113,500 shares of Supernus Pharmaceuticals worth $5.87M as of Q1 2026.
  • Swiss National Bank bought 2,900 Supernus Pharmaceuticals shares in Q1 2026, an estimated $148K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1270 holding.
  • Swiss National Bank first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.